FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
25,322,589
Share change
-1,359,982
Total reported value
$57,483,608
Put/Call ratio
63%
Price per share
$2.27
Number of holders
79
Value change
-$5,167,576
Number of buys
32
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2020

As of 31 Mar 2020, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,322,589 shares. The largest 10 holders included BVF INC/IL, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and ACADIAN ASSET MANAGEMENT LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.